Literature DB >> 23278567

Fatal diabetic ketoacidosis and antipsychotic medication.

Susan F Ely1, Amber R Neitzel, James R Gill.   

Abstract

Hyperglycemia and new onset diabetes have been described with certain antipsychotic medications and some of the initial presentations are fatal diabetic ketoacidosis (DKA). We report 17 deaths due to DKA in psychiatric patients treated with second generation antipsychotic medications. Death certificates and toxicology data were searched for DKA and hyperglycemia. We reviewed the medical examiner records which included the autopsy, toxicology, police, and medical examiner investigators' reports. The decedents ranged in age from 32 to 57 years (average 48 years). There were 15 men and two women. The immediate cause of death was DKA in all. The psychiatric disorders included: 10 schizophrenia, three bipolar/schizophrenia, two bipolar, and two major depression. The most frequent atypical antipsychotic medications found were quetiapine and olanzapine followed by risperidone. In 16 deaths, we considered the medication as primary or contributory to the cause of death.
© 2012 American Academy of Forensic Sciences.

Entities:  

Keywords:  antipsychotic medication; atypical antipsychotics; diabetes; fatality; forensic pathology; forensic sciences; ketoacidosis

Mesh:

Substances:

Year:  2012        PMID: 23278567     DOI: 10.1111/1556-4029.12044

Source DB:  PubMed          Journal:  J Forensic Sci        ISSN: 0022-1198            Impact factor:   1.832


  6 in total

1.  Fatal hypertriglyceridaemia, acute pancreatitis and diabetic ketoacidosis possibly induced by quetiapine.

Authors:  Kristian Roerbaek Madsen
Journal:  BMJ Case Rep       Date:  2014-01-08

2.  Life-threatening ketoacidosis in a pregnant woman with psychotic disorder.

Authors:  Charlotte Frise; Ben Attwood; Peter Watkinson; Lucy Mackillop
Journal:  Obstet Med       Date:  2015-12-24

Review 3.  An approach to iatrogenic deaths.

Authors:  Angela R McGuire; Maura E DeJoseph; James R Gill
Journal:  Forensic Sci Med Pathol       Date:  2016-01-28       Impact factor: 2.007

Review 4.  An overview of diabetes management in schizophrenia patients: office based strategies for primary care practitioners and endocrinologists.

Authors:  Aniyizhai Annamalai; Cenk Tek
Journal:  Int J Endocrinol       Date:  2015-03-23       Impact factor: 3.257

5.  Acute-Onset Type 1 Diabetes that Developed During the Administration of Olanzapine.

Authors:  Kenji Iwaku; Fumiko Otuka; Matsuo Taniyama
Journal:  Intern Med       Date:  2017-02-01       Impact factor: 1.271

6.  Prevention of antipsychotic-induced hyperglycaemia by vitamin D: a data mining prediction followed by experimental exploration of the molecular mechanism.

Authors:  Takuya Nagashima; Hisashi Shirakawa; Takayuki Nakagawa; Shuji Kaneko
Journal:  Sci Rep       Date:  2016-05-20       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.